Hepatitis B Virus X Protein-Induced Aberrant Epigenetic Modifications Contributing to Human Hepatocellular Carcinoma Pathogenesis

Molecular and Cellular Biology

Volumn 33, Issue 15, 2013, Pages 2810-2816

  Tian, Yi ^a   Yang, Weibing ^b   Song, Jianxun ^c   Wu, Yuzhang ^a   Ni, Bing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b First Kidney Transplantation and Hemopurification Center of Chinese PLA   (China)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; BIOLOGICAL MARKER; CIRCULAR DNA; COVALENTLY CLOSED CIRCULAR DNA; CYCLIN D1; DNA; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; HEPATITIS B VIRUS X PROTEIN; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE H3; MICRORNA; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; RETINAL DEHYDROGENASE; RETINAL DEHYDROGENASE 1; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER INHIBITION; CANCER PATIENT; CANCER RESEARCH; CANCER TISSUE; CELL ADHESION; CHROMATIN IMMUNOPRECIPITATION; DEACETYLATION; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE MAPPING; GENE TARGETING; HEPATITIS B; HEPATITIS B VIRUS; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; MOLECULAR DYNAMICS; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; TUMOR SUPPRESSOR GENE; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CARCINOMA, HEPATOCELLULAR; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER; LIVER NEOPLASMS; TRANS-ACTIVATORS;

EID: 84880674407     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00205-13     Document Type: Article

References (83)

1. Kew MC. 2010. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol. Biol. (Paris) 58:273-277.
2. Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH. 1993. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J. Virol. 67:1218-1226.
3. Zoulim F, Saputelli J, Seeger C. 1994. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68:2026-2030.
4. Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C, Levrero M. 1997. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc. Natl. Acad. Sci. U. S. A. 94:8162-8167.
5. Lee AT, Ren J, Wong ET, Ban KH, Lee LA, Lee CG. 2005. The hepatitis B virus X protein sensitizes HepG2 cells to UV light-induced DNA damage. J. Biol. Chem. 280:33525-33535.
6. Lee YI, Hwang JM, Im JH, Kim NS, Kim DG, Yu DY, Moon HB, Park SK. 2004. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J. Biol. Chem. 279:15460-15471.
7. Takada S, Shirakat Y, Kaneniwa N, Koike K. 1999. Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death. Oncogene 18:6965-6973.
8. Ng SA, Lee C. 2011. Hepatitis B virus X gene and hepatocarcinogenesis. J. Gastroenterol. 46:974-990.
9. Unsal H, Yakicier C, Marcais C, Kew M, Volkmann M, Zentgraf H, Isselbacher KJ, Ozturk M. 1994. Genetic heterogeneity of hepatocellular carcinoma. Proc. Natl. Acad. Sci. U. S. A. 91:822-826.
10. Chen GG, Li MY, Ho RL, Chak EC, Lau WY, Lai PB. 2005. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma. J. Clin. Virol. 34:7-12.
11. Iavarone M, Trabut JB, Delpuech O, Carnot F, Colombo M, Kremsdorf D, Brechot C, Thiers V. 2003. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. J. Hepatol. 39:253-261.
12. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C. 1999. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 18:4848-4859.
13. Yeh CT, Shen CH, Tai DI, Chu CM, Liaw YF. 2000. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Oncogene 19:5213-5220.
14. Wollersheim M, Debelka U, Hofschneider PH. 1988. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 3:545-552.
15. Paterlini P, Poussin K, Kew M, Franco D, Brechot C. 1995. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21:313-321.
16. Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Brechot P, Brechot C, Kremsdorf D. 2001. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res. 61:7803-7810.
17. Baylin SB. 2005. DNA methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol. 2(Suppl 1):S4-S11.
18. Herceg Z. 2007. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 22:91-103.
19. Sawan C, Vaissiere T, Murr R, Herceg Z. 2008. Epigenetic drivers and genetic passengers on the road to cancer. Mutat. Res. 642:1-13.
20. Vaissière T, Sawan C, Herceg Z. 2008. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat. Res. 659:40-48.
21. Li B, Carey M, Workman JL. 2007. The role of chromatin during transcription. Cell 128:707-719.
22. Herman JG, Baylin SB. 2003. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349:2042-2054.
23. Chen T, Li E. 2004. Structure and function of eukaryotic DNA methyltransferases. Curr. Top. Dev. Biol. 60:55-89.
24. Goel A, Mathupala SP, Pedersen PL. 2003. Glucose metabolism in cancer. Evidence that demethylation events play a role in activating type II hexokinase gene expression. J. Biol. Chem. 278:15333-15340.
25. Kew MC. 2011. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J. Gastroenterol. Hepatol. 26(Suppl 1):144-152.
26. Herceg Z, Paliwal A. 2011. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat. Res. 727:55-61.
27. Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI. 2007. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132:1476-1494.
28. Pogribny IP, Rusyn I. 2 February 2012. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett. [Epub ahead of print.] doi:10.1016/j.canlet.2012.01.038.
29. Zhu YZ, Zhu R, Fan J, Pan Q, Li H, Chen Q, Zhu HG. 2010. Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis. J. Viral Hepat. 17:98-107.
30. Lee JO, Kwun HJ, Jung JK, Choi KH, Min DS, Jang KL. 2005. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 24:6617-6625.
31. Jung JK, Arora P, Pagano JS, Jang KL. 2007. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res. 67:5771-5778.
32. Park SH, Jung JK, Lim JS, Tiwari I, Jang KL. 2011. Hepatitis B virus X protein overcomes all-trans retinoic acid-induced cellular senescence by downregulating levels of p16 and p21 via DNA methylation. J. Gen. Virol. 92:1309-1317.
33. Endo K, Ueda T, Ueyama J, Ohta T, Terada T. 2000. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum. Pathol. 31:558-565.
34. Hirohashi S, Kanai Y. 2003. Cell adhesion system and human cancer morphogenesis. Cancer Sci. 94:575-581.
35. Osada T, Sakamoto M, Ino Y, Iwamatsu A, Matsuno Y, Muto T, Hirohashi S. 1996. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 24:1460-1467.
36. Liu J, Lian Z, Han S, Waye MM, Wang H, Wu MC, Wu K, Ding J, Arbuthnot P, Kew M, Fan D, Feitelson MA. 2006. Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene 25:1008-1017.
37. Jogie-Brahim S, Feldman D, Oh Y. 2009. Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr. Rev. 30:417-437.
38. Calvisi DF, Ladu S, Gorden A, Farina M, Lee JS, Conner EA, Schroeder I, Factor VM, Thorgeirsson SS. 2007. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J. Clin. Invest. 117:2713-2722.
39. TischoffI, Tannapfe A. 2008. DNA methylation in hepatocellular carcinoma. World J. Gastroenterol. 14:1741-1748.
40. Su PF, Lee TC, Lin PJ, Lee PH, Jeng YM, Chen CH, Liang JD, Chiou LL, Huang GT, Lee HS. 2007. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. Int. J. Cancer 121:1257-1264.
41. Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ. 2002. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clin. Cancer Res. 8:1087-1092.
42. Zhou T, Evans AA, London WT, Xia X, Zou H, Shen F, Clapper ML. 1997. Glutathione S-transferase expression in hepatitis B virus-associated human hepatocellular carcinogenesis. Cancer Res. 57:2749-2753.
43. Niu D, Zhang J, Ren Y, Feng H, Chen WN. 2009. HBx genotype D represses GSTP1 expression and increases the oxidative level and apoptosis in HepG2 cells. Mol. Oncol. 3:67-76.
44. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T, Lu X. 2001. ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell 8:781-794.
45. Zhao J, Wu G, Bu F, Lu B, Liang A, Cao L, Tong X, Lu X, Wu M, Guo Y. 2010. Epigenetic silence of ankyrin-repeat-containing, SH3-domaincontaining, and proline-rich-region-containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology 51:142-153.
46. Lu DD, Chen YC, Zhang XR, Cao XR, Jiang HY, Yao L. 2003. The relationship between metallothionein-1F (MT1F) gene and hepatocellular carcinoma. Yale J. Biol. Med. 76:55-62.
47. Zheng DL, Zhang L, Cheng N, Xu X, Deng Q, Teng XM, Wang KS, Zhang X, Huang J, Han ZG. 2009. Epigenetic modification induced by hepatitis B virus X protein via interaction with de novoDNAmethyltransferase DNMT3A. J. Hepatol. 50:377-387.
48. Aoudjehane L, Podevin P, Scatton O, Jaffray P, Dusanter-Fourt I, Feldmann G, Massault PP, Grira L, Bringuier A, Dousset B, Chouzenoux S, Soubrane O, Calmus Y, Conti F. 2007. Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway. FASEB J. 21:1433-1444.
49. Tong A, Gou L, Lau QC, Chen B, Zhao X, Li J, Tang H, Chen L, Tang M, Huang C, Wei YQ. 2009. Proteomic profiling identifies aberrant epigenetic modifications induced by hepatitis B virus X protein. J. Proteome Res. 8:1037-1046.
50. Jin B, Li Y, Robertson KD. 2011. DNA methylation: superior or subordinate in the epigenetic hierarchy? Genes Cancer 2:607-617.
51. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128:693-705.
52. Chan HM, La Thangue NB. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363-2373.
53. Cougot D, Wu Y, Cairo S, Caramel J, Renard CA, Levy L, Buendia MA, Neuveut C. 2007. The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J. Biol. Chem. 282:4277-4287.
54. Lévy L, Neuveut C, Renard CA, Charneau P, Branchereau S, Gauthier F, Van Nhieu JT, Cherqui D, Petit-Bertron AF, Mathieu D, Buendia MA. 2002. Transcriptional activation of interleukin-8 by beta-catenin-Tcf4. J. Biol. Chem. 277:42386-42393.
55. Matsushima K, Oppenheim JJ. 1989. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1:2-13.
56. Mahé Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S. 1991. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancerbinding protein-like cis-elements. J. Biol. Chem. 266:13759-13763.
57. Yu Y, Song C, Zhang Q, Dimaggio PA, Garcia BA, York A, Carey MF, Grunstein M. 2012. Histone H3 lysine 56 methylation regulates DNA replication through its interaction with pCNA. Mol. Cell 46:7-17.
58. Arzumanyan A, Friedman T, Kotei E, Ng IO, Lian Z, Feitelson MA. 2012. Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene 31:563-572.
59. Shon JK, Shon BH, Park IY, Lee SU, Fa L, Chang KY, Shin JH, Lee YI. 2009. Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription. Virus Res. 139:14-21.
60. Hamamoto R, Furukawa Y, Morita M, Iimura Y, Silva FP, Li M, Yagyu R, Nakamura Y. 2004. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat. Cell Biol. 6:731-740.
61. Hamamoto R, Silva FP, Tsuge M, Nishidate T, Katagiri T, Nakamura Y, Furukawa Y. 2006. Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci. 97:113-118.
62. Yang L, He J, Chen L, Wang G. 2009. Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells. Med. Oncol. 26:445-451.
63. Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P, Buendia MA. 1997. The hepatitis B virus X gene potentiates c-mycinduced liver oncogenesis in transgenic mice. Oncogene 14:395-404.
64. Kalra N, Kumar V. 2006. The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc. FEBS Lett. 580:431-436.
65. Maguire HF, Hoeffler JP, Siddiqui A. 1991. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252:842-844.
66. Yang L, Ma Z, Wang D, Zhao W, Chen L, Wang G. 2010. MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma. Cancer Biol. Ther. 9:803-808.
67. Zhang X, Liu S, Hu T, He Y, Sun S. 2009. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50:490-499.
68. Kong G, Zhang J, Zhang S, Shan C, Ye L, Zhang X. 2011. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One 6:e19518. doi:10.1371/journal.pone.0019518.
69. Yuan K, Lian Z, Sun B, Clayton MM, Ng IO, Feitelson MA. 2012. Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS One 7:e35331. doi:10.1371/journal.pone.0035331.
70. Bui-Nguyen TM, Pakala SB, Sirigiri DR, Martin E, Murad F, Kumar R. 2010. Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J. Biol. Chem. 285:6980-6986.
71. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. 2008. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U. S. A. 105:1608-1613.
72. Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi LL, Lee CG.2010. Lethal-7 is down-regulatedbythe hepatitisBvirus x proteinandtargets signal transducer and activator of transcription 3. J. Hepatol. 53:57-66.
73. Shan C, Zhang S, Cui W, You X, Kong G, Du Y, Qiu L, Ye L, Zhang X. 2011. Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. Carcinogenesis 32:1190-1197.
74. Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X, Wu Z. 2013. miR-101 is down-regulated by the hepatitis B virus X protein and induces aberrantDNA methylation by targeting DNA methyltransferase 3A. Cell. Signal. 25:439-446.
75. Huang J, Wang Y, Guo Y, Sun S. 2010. Down-regulated microRNA-152 induces aberrantDNAmethylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 52:60-70.
76. Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, Zhu Z, Jiao H, Lin J, Jiang K, Ding L, Zhang H, Cheng L, Fu H, Song Y, Jiang Y, Liu J, Wang R, Du N, Ye Q. 2013. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J. Clin. Invest. 123:630-645.
77. Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J, Song E. 2011. Hepatitis B virusXprotein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br. J. Cancer 105:146-153.
78. Newbold JE, Xin H, Tencza M, Sherman G, Dean J, Bowden S, Locarnini S. 1995. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J. Virol. 69:3350-3357.
79. Pollicino T, Belloni L, Raffa G, Pediconi N, Squadrito G, Raimondo G, Levrero M. 2006. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 130:823-837.
80. Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, Raimondo G, Levrero M. 2009. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc. Natl. Acad. Sci. U. S. A. 106:19975-19979.
81. Lucifora J, Arzberger S, Durantel D, Belloni L, Strubin M, Levrero M, Zoulim F, Hantz O, Protzer U. 2011. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J. Hepatol. 55:996-1003.
82. Cougot D, Allemand E, Riviere L, Benhenda S, Duroure K, Levillayer F, Muchardt C, Buendia MA, Neuveut C. 2012. Inhibition of PP1 phosphatase activity by HBx: a mechanism for the activation of hepatitis B virus transcription. Sci. Signal. 5:ra1. doi:10.1126/scisignal.2001906.
83. Jung JK, Park SH, Jang KL. 2010. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation. J. Gen. Virol. 91:493-500.